Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant | Radius Health, Inc.

The Investor Relations website contains information about Radius Health, Inc.’s business for stockholders, potential investors, and financial analysts.

Read the full article here

Related Articles